Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Agric Food Chem ; 72(18): 10355-10365, 2024 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-38620073

RESUMO

The genus Bifidobacterium has been widely used in functional foods for health promotion due to its beneficial effects on human health, especially in the gastrointestinal tract (GIT). In this study, we characterize the anti-inflammatory potential of the probiotic strain Bifidobacterium pseudocatenulatum G7, isolated from a healthy male adult. G7 secretion inhibited inflammatory response in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Moreover, oral administration of bacteria G7 alleviated the severity of colonic inflammation in dextran sulfate sodium (DSS)-treated colitis mice, which was evidenced by a decreased disease activity index (DAI) and enhanced structural integrity of the colon. The 16S rRNA gene sequencing result illustrated that the G7 alleviated DSS-induced gut microbiota dysbiosis, accompanied by the modulated bile acids and short-chain fatty acid (SCFA) levels. Overall, our results demonstrated the potential anti-inflammatory effects of Bifidobacterium pseudocatenulatum G7 on both in vitro and in vivo models, which provided a solid foundation for further development of a novel anti-inflammatory probiotic.


Assuntos
Anti-Inflamatórios , Bifidobacterium pseudocatenulatum , Colite , Microbioma Gastrointestinal , Probióticos , Probióticos/administração & dosagem , Probióticos/farmacologia , Camundongos , Animais , Células RAW 264.7 , Masculino , Anti-Inflamatórios/administração & dosagem , Humanos , Colite/microbiologia , Colite/terapia , Colite/induzido quimicamente , Bifidobacterium pseudocatenulatum/genética , Bifidobacterium pseudocatenulatum/química , Camundongos Endogâmicos C57BL , Macrófagos/imunologia , Ácidos Graxos Voláteis/metabolismo , Colo/microbiologia , Colo/imunologia
2.
Int J Med Sci ; 14(5): 444-451, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28539820

RESUMO

Aims.Bifidobacterium pseudocatenulatum CECT 7765 improves metabolic and immunological altered functions in high fat fed mice, however little is known about the effects of potential probiotics on vascular reactivity. The aim of the present study was to investigate the effects of a potential probiotic strain, Bifidobacterium pseudocatenulatum CECT 7765, on vascular response in obese mice. Methods. Aorta samples were obtained from mice, which were divided into three groups: a control group, receiving a standard diet; an obese group, receiving a high-fat diet; and an obese group receiving high-fat diet and a daily dose of B. pseudocatenulatum CECT 7765 by oral gavage. Aortic rings were suspended in organ baths for isometric recording of tension. mRNA expression of eNOS was evaluated by real-time polymerase chain reaction. Results. Contractions induced by KCl, noradrenaline and thromboxane analogue were 33%, 30% and 45% lower respectively in aortic rings from obese mice. Bifidobacteria administration reversed this effect. eNOS inhibition increased the response to noradrenaline in the three groups with a significant lower magnitude in aortic rings from obese mice receiving bifidobacteria supplement. Acetylcholine caused a greater vasodilation in aorta from obese group (46±3% for control and 69±4% for obese group; p<0.05) and bifidobacteria reversed it (57±5%). Response to sodium nitroprusside was displaced 2.9 times to the left in a parallel manner in obese group. Relaxation to sodium nitroprusside remained unchanged in the bifidobacteria fed group. There was about five-fold decreased mRNA expression of eNOS in aortic segments from the group receiving bifidobacteria. Conclusion.Bifidobacterium pseudocatenulatum CECT 7765 restores the obesity-induced altered vascular function mainly by reducing nitric oxide release.


Assuntos
Bifidobacterium pseudocatenulatum/química , Óxido Nítrico Sintase Tipo III/genética , Obesidade/dietoterapia , Probióticos/administração & dosagem , Animais , Dieta Hiperlipídica/efeitos adversos , Suplementos Nutricionais , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Camundongos , Camundongos Obesos , Óxido Nítrico/metabolismo , Nitroprussiato/administração & dosagem , Obesidade/genética , Obesidade/patologia , Probióticos/química , Remodelação Vascular/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA